Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization

Wael Soliman; Henrik Lund-Andersen; Michael Larsen

doi:10.1111/j.1600-0420.2006.00736.x

Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization

Wael Soliman, Henrik Lund-Andersen, Michael Larsen

33 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Acta Ophthalmologica Scandinavica
Vol/bind	84
Udgave nummer	5
Sider (fra-til)	707-8
Antal sider	2
ISSN	1395-3907
DOI	https://doi.org/10.1111/j.1600-0420.2006.00736.x
Status	Udgivet - okt. 2006
Udgivet eksternt	Ja

Adgang til dokumentet

10.1111/j.1600-0420.2006.00736.x

Citationsformater

@article{70586225fd1140d8ad24d07a9eca783d,

title = "Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization",

keywords = "Adult, Angiogenesis Inhibitors/therapeutic use, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal, Humanized, Bevacizumab, Body Fluids/metabolism, Choroidal Neovascularization/diagnosis, Exudates and Transudates/metabolism, Female, Fluorescein Angiography, Humans, Injections, Retinal Hemorrhage/diagnosis, Retinal Neovascularization/diagnosis, Tomography, Optical Coherence, Vascular Endothelial Growth Factor A/antagonists & inhibitors, Visual Acuity, Vitreous Body",

author = "Wael Soliman and Henrik Lund-Andersen and Michael Larsen",

year = "2006",

month = oct,

doi = "10.1111/j.1600-0420.2006.00736.x",

language = "English",

volume = "84",

pages = "707--8",

journal = "Acta Ophthalmologica Scandinavica",

issn = "1395-3907",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization

AU - Soliman, Wael

AU - Lund-Andersen, Henrik

AU - Larsen, Michael

PY - 2006/10

Y1 - 2006/10

KW - Adult

KW - Angiogenesis Inhibitors/therapeutic use

KW - Antibodies, Monoclonal/therapeutic use

KW - Antibodies, Monoclonal, Humanized

KW - Bevacizumab

KW - Body Fluids/metabolism

KW - Choroidal Neovascularization/diagnosis

KW - Exudates and Transudates/metabolism

KW - Female

KW - Fluorescein Angiography

KW - Humans

KW - Injections

KW - Retinal Hemorrhage/diagnosis

KW - Retinal Neovascularization/diagnosis

KW - Tomography, Optical Coherence

KW - Vascular Endothelial Growth Factor A/antagonists & inhibitors

KW - Visual Acuity

KW - Vitreous Body

U2 - 10.1111/j.1600-0420.2006.00736.x

DO - 10.1111/j.1600-0420.2006.00736.x

M3 - Journal article

C2 - 16965507

SN - 1395-3907

VL - 84

SP - 707

EP - 708

JO - Acta Ophthalmologica Scandinavica

JF - Acta Ophthalmologica Scandinavica

IS - 5

ER -